Literature DB >> 6134737

Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly.

F Cabral, L Wible, S Brenner, B R Brinkley.   

Abstract

In the accompanying paper (Cabral, F., 1982, J. Cell. Biol., 97:22-29) we described the isolation and properties of taxol-requiring mutants of Chinese hamster ovary cells. We now show that at least one of these mutants, Tax-18, has an impaired ability to form a spindle apparatus. Immunofluorescence studies using antibodies to tubulin demonstrate that, when incubated in the absence of taxol, Tax-18 forms only a rudimentary spindle with few and shortened microtubules associated with the spindle poles. Furthermore, midbodies were not observed, consistent with an absence of cytokinesis. Essentially normal spindles and midbodies are seen in the presence of taxol. Electron microscopic examination indicates that centrioles and kinetochores are morphologically normal in the mutant strain. Pole-to-kinetochore microtubules were seen but interpolar microtubules were not. Taxol-deprived mutant cells stained with anti-centrosome serum show an elevated centriole content, indicating that the defect in Tax-18 does not affect centriole replication or prevent progression through the cell cycle. Although Tax-18 cells do not form a complete spindle in the absence of taxol, cytoplasmic microtubule assembly occurs in association with microtubule-organizing centers, and microtubules with apparently normal morphology exist throughout the cytoplasm. Observation of chromosome movement indicates that the defect in these cells occurs after prometaphase. These studies demonstrate that the formation of spindle microtubules requires cellular conditions that are different from those required for cytoplasmic microtubule formation. They further show that a normal spindle may be necessary for cytokinesis but not for progress of the cells through the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134737      PMCID: PMC2112497          DOI: 10.1083/jcb.97.1.30

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  24 in total

Review 1.  Action of drugs on microtubules.

Authors:  L Wilson
Journal:  Life Sci       Date:  1975-08-01       Impact factor: 5.037

2.  Immunofluorescence of mitotic spindles by using monospecific antibody against bovine brain tubulin.

Authors:  G M Fuller; B R Brinkley; J M Boughter
Journal:  Science       Date:  1975-03-14       Impact factor: 47.728

3.  Cytoplasmic microtubules in tissue culture cells appear to grow from an organizing structure towards the plasma membrane.

Authors:  M Osborn; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

4.  Cold-labile and cold-stable microtubules in the mitotic spindle of mammalian cells.

Authors:  B R Brinkley; J Cartwright
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

5.  Light and electron microscopy of rat kangaroo cells in mitosis. II. Kinetochore structure and function.

Authors:  U P Roos
Journal:  Chromosoma       Date:  1973       Impact factor: 4.316

6.  The effects of colcemid inhibition and reversal on the fine structure of the mitotic apparatus of Chinese hamster cells in vitro.

Authors:  B R Brinkley; E Stubblefield; T C Hsu
Journal:  J Ultrastruct Res       Date:  1967-07

7.  Analysis of cleavage stimulus by means of micromanipulation of sea urchin eggs.

Authors:  Y Hiramoto
Journal:  Exp Cell Res       Date:  1971-10       Impact factor: 3.905

8.  Cytoplasmic microtubules in normal and transformed cells in culture: analysis by tubulin antibody immunofluorescence.

Authors:  B R Brinkley; E M Fuller; D P Highfield
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

9.  Ultrastructural analysis of mitotic spindle elongation in mammalian cells in vitro. Direct microtubule counts.

Authors:  B R Brinkley; J Cartwright
Journal:  J Cell Biol       Date:  1971-08       Impact factor: 10.539

10.  The centriole cycle in synchronized HeLa cells.

Authors:  E Robbins; G Jentzsch; A Micali
Journal:  J Cell Biol       Date:  1968-02       Impact factor: 10.539

View more
  16 in total

Review 1.  Tubulin interacting agents: novel taxanes and epothilones.

Authors:  Neeraj R Agrawal; Ram Ganapathi; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

2.  A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation.

Authors:  Rajat Bhattacharya; Fernando Cabral
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

Review 3.  Drug discovery targeting cell division proteins, microtubules and FtsZ.

Authors:  Iwao Ojima; Kunal Kumar; Divya Awasthi; Jacob G Vineberg
Journal:  Bioorg Med Chem       Date:  2014-03-05       Impact factor: 3.641

Review 4.  New microtubular agents in pediatric oncology.

Authors:  N L Seibel; G H Reaman
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

Review 5.  Promising new agents in the treatment of non-small cell lung cancer.

Authors:  M J Edelman; D R Gandara
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

Review 6.  Risks and benefits of taxanes in breast and ovarian cancer.

Authors:  L B Michaud; V Valero; G Hortobagyi
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

7.  2,4-Dichlorobenzyl thiocyanate, an antimitotic agent that alters microtubule morphology.

Authors:  I Abraham; R L Dion; D M Chi; M M Gottesman; E Hamel
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  Design, synthesis, and biological evaluation of new-generation taxoids.

Authors:  Iwao Ojima; Jin Chen; Liang Sun; Christopher P Borella; Tao Wang; Michael L Miller; Songnian Lin; Xudong Geng; Larisa Kuznetsova; Chuanxing Qu; David Gallager; Xianrui Zhao; Ilaria Zanardi; Shujun Xia; Susan B Horwitz; Jon Mallen-St Clair; Jennifer L Guerriero; Dafna Bar-Sagi; Jean M Veith; Paula Pera; Ralph J Bernacki
Journal:  J Med Chem       Date:  2008-05-09       Impact factor: 7.446

9.  Random mutagenesis of β-tubulin defines a set of dispersed mutations that confer paclitaxel resistance.

Authors:  Shanghua Yin; Changqing Zeng; Malathi Hari; Fernando Cabral
Journal:  Pharm Res       Date:  2012-06-06       Impact factor: 4.200

Review 10.  Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy.

Authors:  Hend M Nawara; Said M Afify; Ghmkin Hassan; Maram H Zahra; Akimasa Seno; Masaharu Seno
Journal:  Biomedicines       Date:  2021-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.